Senior Manager, Clinical Quality Assurance and Quality Systems
COUR Pharmaceuticals
This listing was originally posted on COUR Pharmaceuticals's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moAbout the role
The Senior Manager of Clinical Quality Assurance and Quality Systems will be responsible for maintaining GCP compliance of all Clinical Operations, including participating in standing and ad-hoc CRO and Study Team meetings; oversight of data flows, protocol amendment and deviation activities, and training plans; performing compliance review of study-related documentation; and overseeing clinical vendor qualification activities (audits, monitoring, recordkeeping, etc.). This individual will also participate in enterprise level forums (Safety Review Board, Quality Management Review, etc.) and will lead audit and inspection preparation activities to ensure GCP inspection readiness.
In addition to the primary GCP-specific responsibilities, this individual will also have accountability for assigned workflows and Quality Management Systems (QMS) improvement projects, including user administration in eQMS and oversight of IT systems compliance. This role will report directly into the Vice President of Quality and will also have defined accountability to the broader COUR Leadership Team.
What you'll do
Qualifications
The level of this position will be based on the final candidate’s qualifications.
Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities, and activities may change at any time with or without notice.
About COUR
COUR Pharmaceuticals is developing first-in-class therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. COUR’s platform of immune-modifying nanoparticles aims to treat the root cause of immune disease, unlike traditional approaches, which only minimize symptoms using toxic immune suppression.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at COUR Pharmaceuticals?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Nanoparticles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo